Breast cancer is a complex disease, and its progression is difficult, yet import...
With almost 250 million cases a year, 621,000 of them fatal, malaria remains a m...
A new SGD 77 million research initiative has been launched today at the National...
HOUSTON ― Researchers from The University of Texas MD Anderson Cancer Center fou...
As a part of its life cycle, the human immunodeficiency virus-1 (HIV) inserts a ...
The good news: a monoclonal antibody treatment called benralizumab proved quite ...
Virginia Tech researchers with the Fralin Biomedical Research Institute at VTC h...
Novartis, the Swiss pharmaceutical giant, is set to bolster its kidney disease p...
Confo Therapeutics’s technology stabilises the selected GPCRs in their disease-r...
Healthcare R&D teams are increasingly using AI for drug development. Learn more ...
The use of AI in clinical trials is improving pharmaceutical R&D, speeding up ti...
Developing a new drug is a monumental achievement — the reward of years of resea...
The sNDA was submitted based on data obtained from the Phase III NAPOLI 3 trial.
PEMRYDI RTU is the first and only ready-to-use presentation of pemetrexed for in...
The company hopes to work with stakeholders to improve access to biosimilars acr...
Eloxx reanalysed data from a Phase II trial that previously missed its efficacy ...
